Debug Stats | ### Total Build Time: 64 ms 51.693 KB CONCEPT_NAME gt=2 ms Completed: 2 ms rowSize= 352 bytesCONCEPT_SOLR_HIT_STATS gt=0 Completed: 0 ms rowSize= 14 bytesCONCEPT_DEFINITION gt=0 Completed: 0 ms rowSize= 310 bytes- Skipping details on:
CONCEPT_SYNONYM gt=NONE 0 Completed: 0 ms rowSize= 0 bytes - Skipping details on:
CONCEPT_TEXT gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_SEMANTIC_TYPE gt=0 Completed: 0 ms rowSize= 187 bytes- Skipping details on:
CONCEPT_NAMESPACE gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_PARENTS gt=4 ms Completed: 4 ms rowSize= 552 bytesCONCEPT_CHILDREN gt=3 ms Completed: 3 ms rowSize= 1.852 KBCONCEPT_ANCESTRAL_ROOTS gt=9 ms Completed: 9 ms rowSize= 4.058 KBCONCEPT_RELATIONSHIPS gt=17 ms Completed: 17 ms rowSize= 15.605 KBCONCEPT_GENES gt=27 ms Completed: 27 ms rowSize= 27.622 KBCONCEPT_XREFS gt=1 ms Completed: 1 ms rowSize= 1.161 KBCONCEPT_ANCILLARY gt=1 ms Completed: 1 ms rowSize= 14 bytes- Reload Stats
|
Genes (162)
Species: human : 162 | |
Human | CTAGE4 | 100128553 | CTAGE family, member 4 | Sero-reactivity against cTAGE-1, cTAGE-4, cTAGE-5A, and cTAGE-5B was found only in tumor patients (cutaneous T cell lymphoma and melanoma). Moreover, cTAGE-1, cTAGE-4, cTAGE-5A, and cTAGE-5B could be detected in most types of tumor tissues and cell lines at variable frequencies, including those of cutaneous T cell lymphoma, melanoma, head and neck squamous cell carcinoma, breast carcinoma, and colon carcinoma. Sero-reactivity against cTAGE-1, cTAGE-4, cTAGE-5A, and cTAGE-5B was found only in tumor patients (cutaneous T cell lymphoma and melanoma). Moreover, cTAGE-1, cTAGE-4, cTAGE-5A, and cTAGE-5B could be detected in most types of tumor tissues and cell lines at variable frequencies, including those of cutaneous T cell lymphoma, melanoma, head and neck squamous cell carcinoma, breast carcinoma, and colon carcinoma. | Human | HIST4H4 | 121504 | histone cluster 4, H4 | High expression of acetylated H4 is more common in aggressive than indolent cutaneous T-cell lymphoma | Human | MAGED4B | 81557 | melanoma antigen family D, 4B | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | TSGA10 | 80705 | testis specific, 10 | Identification of the testis-specific protein 10 (TSGA10) as serologically defined tumour-associated antigen in primary cutaneous T-cell lymphoma. | Human | CTAGE1 | 64693 | cutaneous T-cell lymphoma-associated antigen 1 | Click here to display 5 evidence detail records. | Human | IL21 | 59067 | interleukin 21 | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | DIABLO | 56616 | diablo, IAP-binding mitochondrial protein | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | DEFB103B | 55894 | defensin, beta 103B | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | RHOF | 54509 | ras homolog family member F (in filopodia) | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | TLR9 | 54106 | toll-like receptor 9 | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | IL23A | 51561 | interleukin 23, alpha subunit p19 | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | CCRL1 | 51554 | | CCR10 is expressed in cutaneous T-cell lymphoma. | Human | LUZP4 | 51213 | leucine zipper protein 4 | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | PTPN22 | 26191 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | DNM3 | 26052 | dynamin 3 | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | CADM1 | 23705 | cell adhesion molecule 1 | The phenotypic expression of immunocompetent cells involved in lesions of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) was studied by using monoclonal antibodies specific for T-cell subsets and HLA-DR antigens (OKT3, T4, T6, T8) (BL 6, BL 5, BL 2). The phenotypic expression of immunocompetent cells involved in lesions of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) was studied by using monoclonal antibodies specific for T-cell subsets and HLA DR antigens (OKT3, T4, T6, T8) (BL6, BL2). The phenotype of the cutaneous immunocompetent cells in lesions of cutaneous T cell lymphoma (mycosis fungoides, Sezary syndrome), lichen planus, and chronic graft-vs.-host reaction infiltrates, was examined by the use of monoclonal antibodies directed against T cell populations and Langerhans cells (OKT3, OKT4, OKT5, OKT6, OKT8) (BL2, BL6). | Human | LILRB1 | 10859 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | We investigated the expression of human leukocyte antigen G (HLA-G) and interleukin 10 (IL-10) in conjunction with expression of HLA-G killer-cell inhibitory receptor ligand immunoglobulin-like transcript 2 (ILT2) in 3 CD56+CD4+ and 4 CD8+ cutaneous T-cell lymphomas. | Human | CCL27 | 10850 | chemokine (C-C motif) ligand 27 | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | CXCL13 | 10563 | chemokine (C-X-C motif) ligand 13 | We analysed the immunophenotypic and molecular expression of BCA-1 (B-cell-specific chemokine) and CXCR5 (BCA-1 receptor) in normal skin and different cutaneous lymphoproliferative disorders (cutaneous T-cell lymphoma (CTCL); cutaneous B-cell lymphoma (CBCL); cutaneous B-cell pseudolymphoma (PCBCL)), with the aim of investigating their possible involvement in the pathogenesis of cutaneous B-cell disorders. | Human | IFITM3 | 10410 | interferon induced transmembrane protein 3 | Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas. | Human | HDAC6 | 10013 | histone deacetylase 6 | The immunohistochemical expression of HDAC6 in cutaneous T-cell lymphoma | Human | MAGEC1 | 9947 | melanoma antigen family C, 1 | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | GAB2 | 9846 | GRB2-associated binding protein 2 | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | IL1RL1 | 9173 | interleukin 1 receptor-like 1 | INFERRED, Score=800, UMLKSK CUI: C0079773 | Human | SOCS3 | 9021 | suppressor of cytokine signaling 3 | This study reports on a constitutive SOCS-3 expression in cutaneous T-cell lymphoma (CTCL) cell lines. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma. |
|